Lucas G. Hill

1.0k total citations
46 papers, 653 citations indexed

About

Lucas G. Hill is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Geriatrics and Gerontology. According to data from OpenAlex, Lucas G. Hill has authored 46 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Public Health, Environmental and Occupational Health, 21 papers in Epidemiology and 17 papers in Geriatrics and Gerontology. Recurrent topics in Lucas G. Hill's work include Opioid Use Disorder Treatment (36 papers), Pharmaceutical Practices and Patient Outcomes (17 papers) and Pain Management and Opioid Use (14 papers). Lucas G. Hill is often cited by papers focused on Opioid Use Disorder Treatment (36 papers), Pharmaceutical Practices and Patient Outcomes (17 papers) and Pain Management and Opioid Use (14 papers). Lucas G. Hill collaborates with scholars based in United States, Australia and India. Lucas G. Hill's co-authors include Kirk E. Evoy, Kelly R. Reveles, Kelly C. Lee, Corey S. Davis, Kenneth A. Lawson, Tran H. Tran, Leticia R. Moczygemba, Anne Burns, Patricia R. Freeman and Traci C. Green and has published in prestigious journals such as JAMA, Addiction and Drug and Alcohol Dependence.

In The Last Decade

Lucas G. Hill

43 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas G. Hill United States 16 512 287 184 115 108 46 653
Gillian Leichtling United States 14 591 1.2× 268 0.9× 114 0.6× 232 2.0× 74 0.7× 40 757
Meelee Kim United States 7 470 0.9× 283 1.0× 71 0.4× 117 1.0× 60 0.6× 9 564
Rebecca McDonald United Kingdom 15 779 1.5× 485 1.7× 36 0.2× 190 1.7× 227 2.1× 55 1.0k
Michael A. Yokell United States 10 583 1.1× 386 1.3× 33 0.2× 113 1.0× 199 1.8× 15 735
R. Matt Gladden United States 10 602 1.2× 337 1.2× 29 0.2× 135 1.2× 172 1.6× 12 821
Shoshana V. Aronowitz United States 16 312 0.6× 212 0.7× 25 0.1× 44 0.4× 38 0.4× 47 522
Martha J. Wunsch United States 8 277 0.5× 127 0.4× 31 0.2× 103 0.9× 51 0.5× 16 361
Zoe Weinstein United States 17 833 1.6× 741 2.6× 99 0.5× 100 0.9× 102 0.9× 48 1.0k
Colleen LaBelle United States 13 655 1.3× 666 2.3× 57 0.3× 48 0.4× 41 0.4× 21 941
Darius A. Rastegar United States 18 365 0.7× 348 1.2× 74 0.4× 69 0.6× 86 0.8× 47 851

Countries citing papers authored by Lucas G. Hill

Since Specialization
Citations

This map shows the geographic impact of Lucas G. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas G. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas G. Hill more than expected).

Fields of papers citing papers by Lucas G. Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas G. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas G. Hill. The network helps show where Lucas G. Hill may publish in the future.

Co-authorship network of co-authors of Lucas G. Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas G. Hill. A scholar is included among the top collaborators of Lucas G. Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas G. Hill. Lucas G. Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thornton, J. Douglas, Ekere James Essien, Matthew A. Wanat, et al.. (2025). Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panel. Drug and Alcohol Dependence Reports. 16. 100360–100360.
2.
Hawk, Mary, Joanne Neale, Alex S. Bennett, et al.. (2024). A call for compassionate opioid overdose response. International Journal of Drug Policy. 133. 104587–104587. 12 indexed citations
3.
4.
Claborn, Kasey, Daniel Sledge, Chris Bailey, et al.. (2023). “We do it ourselves”: strengths and opportunities for improving the practice of harm reduction. Harm Reduction Journal. 20(1). 70–70. 5 indexed citations
5.
Jarrett, Jennie B., Jeffrey Bratberg, Anne Burns, et al.. (2023). Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy. Substance Abuse. 44(4). 264–276. 8 indexed citations
6.
Hill, Lucas G., et al.. (2023). Research and scholarly methods: Audit studies. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(5). 521–527. 3 indexed citations
7.
8.
Hill, Lucas G., et al.. (2022). Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists. Journal of the American Pharmacists Association. 63(1). 252–260.e6. 21 indexed citations
9.
Cance, Jessica Duncan, et al.. (2022). A qualitative exploration of unintentional versus intentional exposure to fentanyl among people who use drugs in Austin, TX. Journal of the American Pharmacists Association. 63(1). 317–323. 7 indexed citations
10.
Moczygemba, Leticia R., et al.. (2022). Opioid Harm Reduction: A Scoping Review of Physician and System-Level Gaps in Knowledge, Education, and Practice. Substance Abuse. 43(1). 972–987. 18 indexed citations
11.
Hill, Lucas G., et al.. (2021). Increasingly powerful opioid antagonists are not necessary. International Journal of Drug Policy. 99. 103457–103457. 21 indexed citations
12.
Evoy, Kirk E., Lucas G. Hill, & Corey S. Davis. (2021). Considering the Potential Benefits of Over-the-Counter Naloxone. PubMed. Volume 10. 13–21. 31 indexed citations
13.
Hill, Lucas G., et al.. (2020). Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA. Addiction. 116(6). 1505–1511. 49 indexed citations
14.
Hill, Lucas G., et al.. (2020). Isotonitazene as a contaminant of concern in the illegal opioid supply: A practical synthesis and cost perspective. International Journal of Drug Policy. 86. 102939–102939. 7 indexed citations
15.
Hill, Lucas G., R. Hutchison, Lindsay M. Arnold, et al.. (2020). Mobilizing pharmacists to address the opioid crisis: A joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(8). 1493–1513. 29 indexed citations
16.
Hill, Lucas G., et al.. (2020). Increasing Naloxone Knowledge and Use Through Direct-to-Patient Education. Journal of Pharmacy Technology. 36(6). 237–242. 1 indexed citations
17.
Hill, Lucas G., et al.. (2018). Operation Naloxone: Overdose prevention service learning for student pharmacists. Currents in Pharmacy Teaching and Learning. 10(10). 1348–1353. 30 indexed citations
18.
Hill, Lucas G., et al.. (2017). Naloxone Counseling for Harm Reduction and Patient Engagement.. PubMed. 49(9). 730–733. 15 indexed citations
19.
Bratberg, Jeffrey, et al.. (2017). The Report of the 2016-2017 Advocacy Standing Committee. American Journal of Pharmaceutical Education. 81(8). S10–S10. 4 indexed citations
20.
Hill, Lucas G., et al.. (2016). ACE Inhibitors or ARBs to Prevent CKD in Patients with Microalbuminuria. American family physician. 94(8). 652–653. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillian Leichtling Breakdown of academic impact, for papers by Meelee Kim Breakdown of academic impact, for papers by Rebecca McDonald Breakdown of academic impact, for papers by Michael A. Yokell Breakdown of academic impact, for papers by R. Matt Gladden Breakdown of academic impact, for papers by Shoshana V. Aronowitz Breakdown of academic impact, for papers by Martha J. Wunsch Breakdown of academic impact, for papers by Zoe Weinstein Breakdown of academic impact, for papers by Colleen LaBelle Breakdown of academic impact, for papers by Darius A. Rastegar
Rankless by CCL
2026